Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-02-05 @ 9:01 AM
Study NCT ID:
NCT01662102
Status:
TERMINATED
Last Update Posted:
2021-10-04
First Post:
2012-08-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Follicular Lymphoma | View |
Keywords: